MedTrace Logo

Cessation in Non-Daily Smokers

NCT02168855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 505

Last updated 2020-05-06

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effect of as-needed oral Nicotine Replacement Therapy (NRT) - 2 mg nicotine gum - for smoking cessation in non-daily, or intermittent, smokers, and to study the process of relapse in ITS, using Ecological Momentary Assessment (EMA).

Conditions

  • Smoking

Interventions

DRUG

active nicotine gum

2 mg, standard over-the-counter nicotine replacement therapy gum

BEHAVIORAL

Standard behavioral therapy

Standard behavioral therapy for smoking cessation

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Brian Primack

    lead OTHER

Principal Investigators

  • Brian A Primack, MD, PhD · University of Pittsburgh, Division of General Internal Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02168855 on ClinicalTrials.gov